Axitinib
Showing 201 - 221 of 221
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome Trial in Houston (AG-013736 (Axitinib))
Completed
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome
- AG-013736 (Axitinib)
-
Houston, TexasPfizer Investigational Site
May 31, 2012
Kidney Tumors, Carcinoma, Renal Cell Trial in United States (AG-013736 (axitinib))
Completed
- Kidney Neoplasms
- Carcinoma, Renal Cell
- AG-013736 (axitinib)
-
Chicago, Illinois
- +4 more
Jul 23, 2012
Update 5-Year Survival Of Subjects Who Participated In Axitinib
Completed
- Carcinoma, Renal Cell
- axitinib: observational study
-
San Francisco, California
- +7 more
Apr 18, 2012
Tumors Trial in Poland, Spain, United States (Axitinib + Paclitaxel + Carboplatin (Cohort 1), Axitinib + Paclitaxel +
Completed
- Neoplasms
- Axitinib + Paclitaxel + Carboplatin (Cohort 1)
- +9 more
-
Augusta, Georgia
- +12 more
Mar 30, 2012
Tumors Trial in Kobe-shi (Axitinib (AG-013736))
Completed
- Neoplasms
- Axitinib (AG-013736)
-
Kobe-shi, Hyogo-ken, JapanPfizer Investigational Site
May 17, 2012
Melanoma, Skin Tumors Trial in France, United States (Axitinib [AG-013736])
Completed
- Melanoma
- Skin Neoplasms
- Axitinib [AG-013736]
-
Orange, California
- +11 more
Jun 21, 2012
Lung Tumors, Carcinoma, Non-small Cell Lung Trial in Germany, United States (axitinib)
Completed
- Lung Neoplasms
- Carcinoma, Non-small Cell Lung
- axitinib
-
Irvine, California
- +10 more
Jun 21, 2012
BRAFV600E Intratumor Heterogeneity in Thyroid Cancer Treated
Unknown status
- Differentiated Thyroid Cancer
-
Baronissi, Salerno, ItalyDepartment of Medicine and Surgery, Univeristy of Salerno
Oct 20, 2012
Carcinoma, Renal Cell, Glioblastoma, Carcinoma, Hepatocellular Trial (Crizotinib plus VEGF inhibitor combinations, Crizotinib
Withdrawn
- Carcinoma, Renal Cell
- +2 more
- Crizotinib plus VEGF inhibitor combinations
- +4 more
- (no location specified)
Dec 19, 2011
Kidney Tumors Trial in France, Germany, United States (Vascular Endothelial Growth Factor Receptor [VEGFR] and Platelet-Derived
Completed
- Kidney Neoplasms
- Vascular Endothelial Growth Factor Receptor [VEGFR] and Platelet-Derived Growth Factor Receptor [PDGFR] inhibitor
-
San Francisco, California
- +8 more
Jun 20, 2012
Carcinoma, Pancreatic Ductal Trial in Worldwide (AG-013736, Gemcitabine, )
Advanced Solid Tumors Trial in San Francisco, Houston, Madison (AG-013736)
Completed
- Advanced Solid Tumors
-
San Francisco, California
- +2 more
Feb 25, 2012
Healthy Volunteers Trial in Beijng (AG-013736 (axitinib))
Completed
- Healthy Volunteers
- AG-013736 (axitinib)
-
Beijng, ChinaPfizer Investigational Site
Sep 17, 2009